NIMH Chemical Synthesis and Drug Supply Program

Compound Information Page

Compound Name: 2-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl}-4-methyl-1,2,4-triazine-3,5-(2H,4H)-dione (CUMI-101)
NIMH Code: C-917
Alternative Name: CUMI-101
Abbreviation:
Indications: 5-HT1A receptor PET imaging ligand reference standard
Package Sizes:
References: 1) Kumar, J. S.; Prabhakaran, J.; Majo, V. J.; Milak, M. S.; Hsiung, S. C.; Tamir, H.; Simpson, N. R.; Van Heertum, R. L.; Mann, J. J.; Parsey, R. V. Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 1050-1060. 2) Kumar, J. S.; Majo, V. J.; Hsiung, S. C.; Milak, M. S.; Liu, K. P.; Tamir, H.; Prabhakaran, J.; Simpson, N. R.; Van Heertum, R. L.; Mann, J. J.; Parsey, R. V. J. Med. Chem. 2006, 49, 125-134.
CAS:
Molecular Formula:
HBA:
HBD:
RotB:
PubChemID:
AlogP:
TPSA:
Activity:
Comments:
Last Updated 2010-04-21 11:16 AM
Structure of C-917
About The Program

Since 1959, the NIMH Chemical Synthesis and Drug Supply Program has synthesized and distributed novel research chemicals, psychoactive drugs, and compounds that are unavailable from commercial sources to the scientific community working on research relevant to mental health.

Content © 2014. «RTI International».